Tristel
€5.6
13
+€0+0% Today
Statistics
Day High
5.6
Day Low
5.6
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
276.05M
P/E Ratio
38.33
Dividend Yield
2.71%
Dividend
0.15
Upcoming
14
OCT
Earnings
23
NOV
Dividend Ex
18
DEC
Earnings
22
DEC
Dividend Payment
21
MAR 25
Dividend Ex
12
APR 25
Dividend Payment
23
NOV 25
Dividend Ex
22
DEC 25
Dividend Payment
21
MAR 26
Dividend Ex
12
APR 26
Dividend Payment
Dividends
2.71%Dividend Yield
10Y Growth
21.56%
5Y Growth
18.6%
3Y Growth
25.41%
1Y Growth
25.88%
Earnings
14OctConfirmed
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow R1V.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Ecolab
ECL
Mkt Cap69.44B
Clorox
CLX
Mkt Cap16.78B
Danaher
DHR
Mkt Cap180.39B
Procter & Gamble
PG
Mkt Cap396.41B
Roche
RHHBY
Mkt Cap220.72B
3M
MMM
Mkt Cap57.51B
Stepan
SCL
Mkt Cap2.01B
Johnson & Johnson
JNJ
Mkt Cap372.29B
Becton Dickinson
BDX
Mkt Cap66.69B
About
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Show more...
CEO
Mr. Paul Christopher Swinney
Employees
208
Country
GB
ISIN
GB00B07RVT99
WKN
000A0JDM7